PACS Group/$PACS
PACS shares fell after director and 10% owner Mark Hancock disclosed 300,000 shares sold under a pre-arranged Rule 10b5-1 trading plan.
24 hours agoLightyear AI
1D1W1MYTD1Y5YMAX
Capital at risk
About PACS Group
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
- Ticker
- $PACS
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 47,455
- Headquarters
- Salt Lake City, United States
- Website
- pacs.com
PACS Group Metrics
BasicAdvanced
$6.7B
24.61
$1.71
-0.08
-
Price and volume
Market cap
$6.7B
Beta
-0.08
52-week high
$49.49
52-week low
$10.31
Average daily volume
757K
Financial strength
Current ratio
0.912
Quick ratio
0.842
Long term debt to equity
2.88
Total debt to equity
3.053
Interest coverage (TTM)
13.88%
Profitability
EBITDA (TTM)
478.3
Gross margin (TTM)
17.32%
Net profit margin (TTM)
4.85%
Operating margin (TTM)
7.39%
Effective tax rate (TTM)
29.67%
Revenue per employee (TTM)
$120,000
Management effectiveness
Return on assets (TTM)
4.60%
Return on equity (TTM)
27.92%
Valuation
Price to earnings (TTM)
24.611
Price to revenue (TTM)
1.191
Price to book
6
Price to tangible book (TTM)
6.39
Price to free cash flow (TTM)
14.508
Free cash flow yield (TTM)
6.89%
Free cash flow per share (TTM)
2.901
Growth
Revenue change (TTM)
15.15%
Earnings per share change (TTM)
107.44%
What the Analysts think about PACS Group
Analyst ratings (Buy, Hold, Sell) for PACS Group stock.
Analyst projections of the future price of PACS Group stock.
Bulls say / Bears say
Q2 revenue rose 9.1% year on year and adjusted EBITDA rose 25%, prompting management to lift 2026 EBITDA guidance to $640m–$660m. The upgrade suggests the existing estate is performing ahead of plan, not just benefiting from acquisitions. (PACS Group, Skilled Nursing News)
Occupancy reached 90.4% across the portfolio, against the 79.5% industry average cited by PACS, while mature facilities reached 93.8%. As newer sites mature, the gap between roughly 11% group margins and mid-teens mature-facility margins gives PACS a credible route to further margin expansion. (PACS Group, Skilled Nursing News)
PACS is adding scale through the 34-facility Eduro deal and a proposed 32-facility Florida entry, while its quality performance can support better payer relationships and Medicaid quality-linked payments. The strategy offers both acquisition growth and operating upside if PACS can repeat its facility-improvement playbook. (PACS Group, Skilled Nursing News)
PACS still has unresolved government investigations and previously disclosed material weaknesses in internal controls. Management expects remediation by year-end, but the legal and reporting overhang could still bring penalties, distraction or a lower valuation multiple. (The Motley Fool, Simply Wall St News)
The growth plan is increasing integration demands: the Eduro facilities are being added while a further 32-site Florida transaction is pending. Newly acquired Texas facilities were running at only mid-60% occupancy with roughly 10%–11% skilled mix, so acquisitions can initially add revenue faster than profit and may strain management capacity. (Skilled Nursing News, PACS Group)
The earnings base remains exposed to Medicaid rates and state quality-incentive programmes, while the timing and size of some payments are uncertain. A policy change or weaker reimbursement could pressure margins just as PACS is integrating a larger, more complex estate. (Simply Wall St News, PACS Group)
Data summarised monthly by Lightyear AI. Last updated on 15 Sept 2026.
PACS Group Financial Performance
Revenues and expenses
PACS Group Earnings Performance
Company profitability
Upcoming events
No upcoming events
PACS Group News
AllArticlesVideos
Funds containing PACS Group
AllEURUSDGBP
Fund name | Fund size | $PACS weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.18% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.07% |
iShares MSCI World Small Cap$WSML | $9B | 0.02% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.02% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.02% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.